Abeona Therapeutics (ABEO): A Rare Disease Transformation Story
Applying Our Three-Pillar Investment Framework to an Emerging Gene Therapy Leader (October 15, 2025). At Riverwater Partners our investment process centers on a disciplined three-pillar approach: our approach: exceptional management teams, superior business, and attractive valuation. While Abeona Therapeutics (ABEO) might initially appear to challenge this framework as a recently commercial-stage biotechnology company, we believe…